<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

New FDA-approved sickle cell gene editing therapies offer hope for a pain-free life to patients – some living in Colorado

Default sub title

minute read

placeholder

In December 2023, the Food and Drug Administration (FDA) approved two new gene therapies that can cure sickle cell disease. 

Topics: Press Coverage